Skip to main content
. 2012 Feb;18(6):755–767. doi: 10.2174/138161212799277752

Table 1.

Peptides Selected for In vivo Imaging

Name Sequence Description D/L Results Reference
none DWGKGGRWRLWPGASGKTEA
and
PGRSPFTGKKLFNQEFSQDQ
Selected by phage display L Binds amyloid form of Aβ40, labels amyloid plaques in AD brains slices, discussed as carrier protein for plaque treatment and in vivo imaging Kang et al., 2003 [40]
D1/ ACI-80 ACI-80: QSHYRHISPAQV Selected by mirror image phage display D Aggregate specific, stains human Aβ plaques selectively, stains plaques in mice ex vivo Wiesehan et al., 2003 [46]
Van Groen et al., 2009 [47]
none C-IPLPFYN-C /
C-FRHMTEQ-C
Selected by phage display L Kd for Aβ42 in micromolar range, specific interaction with plaques on brain sections (immunochemistry), encouraging preliminary MRI in vivo study in mice after opening of bbb by mannitol Larbanoix et al., 2008 [48]
Pep1 Pep2 LIAIMA
IFALMG
Selected by phage display, library based on Aβ sequence L Kd for Aβ42 in micromolar range, specific interaction with plaques in human brain sections (immunochemistry), inhibit Aβ aggregation Larbanoix et al., 2011 [49]

bbb: blood brain barrier. D/L: describes peptide conformation.